Showing 2581-2590 of 2807 results for "".
- ISAPS: Brazil, US Remain Cosmetic Surgery Capitals of the Worldhttps://modernaesthetics.com/news/isaps-brazil-us-remain-cosmetic-surgery-capitals-of-the-world/2472850/Driven by increases in non-invasive procedures, plastic surgery across the globe is on the rise, according to the annual statistics from the International Society of Aesthetic Plastic Surgery (ISAPS), and the US and Brazil remain the cosmetic surgery capitals o
- Revance's DAXI Now One Step Closer to FDA Nodhttps://modernaesthetics.com/news/revances-daxi-now-one-step-closer-to-fda-nod/2472849/Revance Therapeutics, Inc. has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for DaxibotulinumtoxinA for Injection (DAXI) in the treatment of moderate to severe glabellar lines. Under
- Kylie Jenner Sells Majority Stake in Beauty Business to Cotyhttps://modernaesthetics.com/news/kylie-jenner-sells-majority-stake-in-beauty-business-to-coty/2472846/Kylie Jenner sold a $600M majority stake in Kylie Cosmetics and Kylie Skin to Coty Inc. Under the terms of the agreement, Coty will acquire a 51 percent ownership in the partnership for $600M. The acquisition is expected to close in the third quarter of fiscal year 2020. Coty's
- Save the Date: November 20, 2019 Marks National Botox Dayhttps://modernaesthetics.com/news/save-the-date-november-20th-2019-marks-national-botox-day/2472845/November 20, 2019 will be the first-ever National Botox Cosmetic Day. Why Nov. 20? It is the busiest day on record for booking Botox cosmetic treatments in the US. And to commemorate it, Allergan is offering an exclusive deal for one day only where patients can “buy one, get
- Venus Concept Completes Merger with Restoration Roboticshttps://modernaesthetics.com/news/venus-concept-completes-merger-with-restoration-robotics/2472842/Venus Concept Inc. has completed its previously announced merger with Restoration Robotic, Inc., effective November 7, 2019. Following the completion of the merger, Venus Concept completed a $28 million equity financing by EW Health
- Update: Instagram Removes Cosmetic Surgery Filtershttps://modernaesthetics.com/news/update-instagram-removes-cosmetic-surgery-filters/2472841/In a move designed to promote mental well being, Instagram, owned by Facebook, is removing all augmented reality filters that depict cosmetic surgery. In addition, the social media giant is striking all effects from the gallery that are associated with plastic surgery and postponing the
- Cynosure Rolls Out StimSure for Muscle Toning in Europe, Middle Easthttps://modernaesthetics.com/news/cynosure-rolls-out-stimsure-for-muscle-toning-in-europe-middle-east/2472839/Cynosure, a division of Hologic, is launching StimSure, a non-invasive electromagnetic technology to build and tone muscle in the abdomen, buttocks and thighs, in Europe and the Middle East. CE marked for muscular atrophy, StimSure can be used to strengthen and tighten the abdomina
- Galderma Set to Start Seven New Clinical Studieshttps://modernaesthetics.com/news/galderma-set-to-start-begin-seven-new-clinical-studies/2472838/Galderma is initiating seven clinical studies that seek to support potential, new aesthetic indications including a tear trough indication for Restylane, a facial wrinkles indication for Sculptra Aesthetic as well as several studies supporting an investigational liquid neurotoxin and a Phase 2 st
- FDA Proposes Boxed Warning on Breast Implant Riskshttps://modernaesthetics.com/news/fda-proposes-boxed-warning-on-breast-implant-risks/2472837/The FDA released a statement on its continued efforts to protect women’s health and enhance safety information available to patients considering breast implants. In draft guidance issued on Oct. 24, the FDA proposed labeling
- Merz: Cellfina for Cellulite Cleared for 5 Years of Benefithttps://modernaesthetics.com/news/merz-cellfina-for-cellulite-cleared-for-5-years-of-benefit/2472836/The FDA has cleared a new indication statement for Cellfina that shows the benefits of treatment last for five years, an increase from the previous three-year indication. Cellfina from Merz demonstrated five-year improvement in the appearance of cellulite on the buttocks and thighs of adult femal